We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $32.4B
1-Year Est. Return 58.5%
This Fund
S&P 500
This Quarter Est. Return
+23.19%
1 Year Est. Return
+58.5%
3 Year Est. Return
+155.34%
5 Year Est. Return
+222.91%
10 Year Est. Return
AUM
$32.4B
AUM Growth
+$5.91B
Cap. Flow
+$1.91B
Cap. Flow %
5.91%
Top 10 Hldgs %
17.19%
Holding
1,187
New
164
Increased
545
Reduced
215
Closed
176

Sector Composition

Rank Sector Weight
1 Healthcare 25.1%
2 Technology 24.74%
3 Financials 10.96%
4 Consumer Discretionary 9.79%
5 Industrials 7.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMVT icon
101
Immunovant
IMVT
$7.83B
$76.1M 0.24%
1,975,869
TRVI icon
102
Trevi Therapeutics
TRVI
$2.32B
$76.1M 0.24%
4,081,333
+3,080,551
+308% +$44.8M
MAR icon
103
Marriott International
MAR
$86.8B
$76M 0.23%
205,039
+57,273
+39% +$21.1M
NEE icon
104
NextEra Energy
NEE
$172B
$75.3M 0.23%
857,575
+450,572
+111% +$40.8M
LHX icon
105
L3Harris
LHX
$46.2B
$75.2M 0.23%
258,932
+62,683
+32% +$19.9M
ALNY icon
106
Alnylam Pharmaceuticals
ALNY
$33.3B
$74.1M 0.23%
246,282
+2,399
+1% +$724K
IAG icon
107
IAMGOLD
IAG
$11.8B
$73.1M 0.23%
4,617,336
+3,202,708
+226% +$56M
TEL icon
108
TE Connectivity
TEL
$60.7B
$72.7M 0.22%
360,478
+349,003
+3,041% +$74.4M
IWM icon
109
iShares Russell 2000 ETF
IWM
$78.7B
$72.1M 0.22%
+240,000
New +$67.4M
TJX icon
110
TJX Companies
TJX
$138B
$71.4M 0.22%
471,312
+315,802
+203% +$49.9M
CNK icon
111
Cinemark Holdings
CNK
$4.07B
$71M 0.22%
2,236,932
+914,889
+69% +$27.2M
CON
112
Concentra Group Holdings
CON
$4.43B
$70.5M 0.22%
2,369,907
+1,359,082
+134% +$33.8M
IRON icon
113
Disc Medicine
IRON
$2.82B
$70.1M 0.22%
958,281
VRTX icon
114
Vertex Pharmaceuticals
VRTX
$130B
$69.7M 0.22%
140,288
+5,334
+4% +$2.36M
NSC icon
115
Norfolk Southern
NSC
$72.2B
$69.5M 0.21%
221,015
+35,136
+19% +$10.8M
LTH icon
116
Life Time Group Holdings
LTH
$9.59B
$69.1M 0.21%
1,691,285
+1,230,668
+267% +$39.1M
THG icon
117
Hanover Insurance
THG
$7.78B
$68.9M 0.21%
321,972
-97,008
-23% -$18.4M
KO icon
118
Coca-Cola
KO
$378B
$68.7M 0.21%
845,250
+78,540
+10% +$6.2M
ZVRA icon
119
Zevra Therapeutics
ZVRA
$718M
$68.6M 0.21%
4,785,771
+1,334,828
+39% +$14.8M
MMM icon
120
3M
MMM
$84.5B
$67.8M 0.21%
418,543
+36,065
+9% +$5.47M
MDGL icon
121
Madrigal Pharmaceuticals
MDGL
$12.5B
$67.6M 0.21%
125,899
CVX icon
122
Chevron
CVX
$423B
$67.5M 0.21%
407,105
+38,447
+10% +$7.16M
BMY icon
123
Bristol-Myers Squibb
BMY
$130B
$67.3M 0.21%
1,167,476
+46,838
+4% +$2.69M
ABG icon
124
Asbury Automotive
ABG
$3.77B
$67M 0.21%
333,243
+56,824
+21% +$11.2M
PRAX icon
125
Praxis Precision Medicines
PRAX
$9.59B
$67M 0.21%
200,013

Similar funds

Woodline Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Woodline Partners held 1,187 positions worth $32.4B, up 22% from $26.4B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Woodline Partners deployed $1.91B of net new capital in Q2 2026, opening 164 new positions and adding to 545 existing holdings. Its largest new stake was SpaceX: 508,235 shares worth $86.8M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Texas Instruments, an estimated $215M trimmed.

  • Woodline Partners's largest Q2 2026 buy was SpaceX: 508,235 shares worth $86.8M.
  • Woodline Partners added most to Meta Platforms (Facebook) in Q2 2026, an estimated $261M increase.
  • Woodline Partners's biggest Q2 2026 reduction was Texas Instruments, cutting an estimated $215M.
  • Woodline Partners fully exited SSR Mining in Q2 2026, selling an estimated $103M.
  • Woodline Partners's ten largest holdings make up 17% of its $32.4B portfolio in Q2 2026.
  • Woodline Partners opened 164 new positions and closed 176 in Q2 2026.
  • Woodline Partners's portfolio value rose 22% quarter-over-quarter to $32.4B.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.